Dr. Myo Htut, MD

Dr. Htut practices at City of Hope Comprehensive Cancer Center - Duarte in Duarte, California.

Dr. Htut's NPI, 1568572592, was assigned on August 30, 2006. Dr. Htut graduated from University Institute of Medicine 1 in 1996. Dr. Htut holds California license A78720.

Dr. Htut's primary practice is City of Hope Comprehensive Cancer Center - Duarte, at 1500 Duarte Rd, Duarte, CA 91010 in Los Angeles County. The practice phone is (800) 826-4673.

Dr. Htut's primary practice is City of Hope Comprehensive Cancer Center - Duarte in Duarte, California. Dr. Htut is also affiliated with San Antonio Regional Hospital. The medical group on file is City of Hope. Dmand AI also links Dr. Htut to 1 more other site, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Htut practices, 2 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Htut's primary specialty in the NPI Registry, under taxonomy code 207RH0000X. The record also lists hematology. Dr. Htut is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Htut's licenses on file in 4 states: California, Colorado, Michigan and Pennsylvania.

Dmand AI lists chronic leukemia, lymphoma, multiple myeloma and neutropenia among the conditions Dr. Htut treats.

CMS data shows 981 Medicare services from Dr. Htut across 5 procedure codes in 2024, for 184 Medicare patients. Medicare paid $93,635 for them.

CMS counts 184 Medicare patients who saw Dr. Htut in 2024. The largest group is 65 to 74, with 98 patients. 73% of them have high blood pressure, and 65% have high cholesterol. 27% are also on Medicaid. Their average risk score is 3.59, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Htut's median patient age at 69, with 50% women.

In 2024, Dr. Htut wrote 272 Medicare Part D claims for 39 patients. 72% of them were for generic drugs. CMS names the drug for 114 of them, across 6 drugs with 11 or more claims each, at $571,938 in total drug cost. In 2023, CMS named 289 claims across 11 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Htut for performance year 2024, reported as part of a group. Dr. Htut accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Htut as offering telehealth.

Dmand AI links 40 papers to Dr. Htut, published from 2011 to 2025. 2023 was the busiest year, with 7. The most frequent topics are Multiple Myeloma, Immunotherapy, Adoptive and Receptors, Chimeric Antigen. Dr. Htut has published most often in Clin Lymphoma Myeloma Leuk. Dr. Htut's most frequent co-authors are Stephen J. Forman, MD, Jesus G. Berdeja, MD and Chatchada Karanes, MD.

Dmand AI links Dr. Htut to 9 clinical trials, 3 of them phase 1 studies. 2 are still active or recruiting. Conditions studied include Multiple Myeloma, Blood Protein Disorders and Iron Overload. City of Hope Medical Center sponsors the most, 2.

CMS Open Payments shows 35 general payments to Dr. Htut from 15 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 81% of the total. Millennium Pharmaceuticals, Inc. paid the most, $294.

Dr. Htut graduated from University Institute of Medicine 1 in 1996.

Dr. Htut is in network with 13 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.